Novel Prognostic Markers in Renal Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

182 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-12-01

Study Completion Date

2014-12-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to analyze tumour tissue from a group of subjects with renal cell carcinoma, who have been treated at the Royal Marsden Hospital.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Identification of Novel Prognostic Markers in Melanoma

NCT01002560

Malignant Melanoma

UNKNOWN

Biomarkers of Renal Cancer

NCT05785052

Renal Cell Carcinoma Tumor, Solid Oncocytoma +1 more

RECRUITING

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

NCT02499458

Clear Cell Renal Cancer Circulating Tumor Cells Circulating Endothelial Cells +2 more

COMPLETED

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

NCT00900276

Bladder Cancer Kidney Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter +1 more

COMPLETED

The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

NCT02450448

Neoplastic Cells, Circulating

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Renal cancers have different clinical outcomes. The principal research objective is to study tumour tissue from renal cancer patients and try and understand why some cancers progress more rapidly than others. Further, another key aim of this study is to try and understand why some patients respond to treatment and others do not.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Cell Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tumour tissue, renal cell carcinoma

\> 2mm x 2mm of tumour tissue obtained from paraffin blocks taken from biopsies or nephrectomy specimens.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The presence of histologically proven renal cell cancer
* The availability of paraffin embedded tissue
* Informed consent needed for tissue taken after January 2006 (date of enforcement of human tissue act)